UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE
OMB APPROVAL
OMB Number:3235-0006
Expires:July 31, 2015
Estimated average burden
hours per response:23.8
Report for the Calendar Year or Quarter Ended:
09-30-2020
Check here if Amendment: ☒ Amendment Number:
1
This Amendment (Check only one.):☒ is a restatement.
☐ adds new holdings entries.

Institutional Investment Manager Filing this Report:

Name:
Logos Global Management LP
Address:
1 LETTERMAN DRIVE
STE. D3-700
San Francisco, CA 94129
Form 13F File Number:
028-20025

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.


Person Signing this Report on Behalf of Reporting Manager:
Name:
Virginia Yee
Title:
CFO/CCO
Phone:
415-801-4660


Signature, Place, and Date of Signing:

/s/ Virginia Yee
                         [Signature]
San Francisco, CALIFORNIA
                 [City, State]
11-17-2020
                           [Date]
                          

Report Type (Check only one.):

☒ 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) 

☐ 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) 

☐ 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)


Form 13F Summary Page

Report Summary:

Number of Other Included Managers:
0
Form 13F Information table Entry Total:
46
Form 13F Information table Value Total:
781397
          (thousands)

List of Other Included Managers:

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state "NONE" and omit the column headings and list entries.]

  
NONE


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number:3235-0006
Expires:July 31, 2015
Estimated average burden
hours per response:23.8
COLUMN 1COLUMN 2COLUMN 3COLUMN 4COLUMN 5COLUMN 6COLUMN 7COLUMN 8
VALUESHRS ORSH/PUT/INVESTMENTOTHERVOTING AUTHORITY
NAME OF ISSUERTITLE OF CLASSCUSIP(x$1000)PRN AMTPRNCALLDISCRETIONMANAGERSOLESHAREDNONE
ACUTUS MED INCCOM0051111092,23575,000SHSOLE75,000 0 0
AKOUOS INCCOM00973J1017,090310,000SHSOLE310,000 0 0
ALX ONCOLOGY HLDGS INCCOM00166B105118,3903,136,981SHSOLE3,136,981 0 0
ANNEXON INCCOM03589W1024,825159,622SHSOLE159,622 0 0
ARYA SCIENCES ACQUISTION COUNIT 06/09/2027G316551141,100100,000SHSOLE100,000 0 0
ATHIRA PHARMA INCCOM04746L10418,8441,020,812SHSOLE1,020,812 0 0
AVIDITY BIOSCIENCES INCCOM05370A10820,309721,454SHSOLE721,454 0 0
BCTG ACQUISITION CORPCOM05492W1032,072200,000SHSOLE200,000 0 0
BIOXCEL THERAPEUTICS INCCOM09075P10523,848550,000SHSOLE550,000 0 0
BLACK DIAMOND THERAPEUTICS ICOM09203E1053,732123,465SHSOLE123,465 0 0
BRISTOL-MYERS SQUIBB CORIGHT 99/99/999911012215712,3755,500,000SHSOLE5,500,000 0 0
CALLIDITAS THERAPEUTICS ABSPONSERED ADS13124Q10613,200550,000SHSOLE550,000 0 0
CELLDEX THERAPEUTICS INC NEWCOM NEW15117B20217,7961,200,000SHSOLE1,200,000 0 0
CHARDAN HEALTHCR ACQSTN 2 COUNIT 99/99/999915957T2062,110200,000SHSOLE200,000 0 0
COMPASS PATHWAYS PLCSPONSORED ADS20451W10117,450500,000SHSOLE500,000 0 0
CYTOKINETICS INCCOM NEW23282W60516,238750,000SHSOLE750,000 0 0
DYNE THERAPEUTICS INCCOM26818M10832,3931,604,392SHSOLE1,604,392 0 0
FORMA THERAPEUTICS HLDGS INCSHS34633R10458,4721,173,188SHSOLE1,173,188 0 0
FS DEV CORPCOM CL A3030201011,120100,000SHSOLE100,000 0 0
GLOBAL BLOOD THERAPEUTICS INCOM37890U10846,869850,000SHSOLE850,000 0 0
HARMONY BIOSCIENCES HLDGS INCOM4131971049,323275,000SHSOLE275,000 0 0
HEALTH SCIENCES ACQ CORP 2ORD SHSG4411D1093,300300,000SHSOLE300,000 0 0
INARI MED INCCOM45332Y1093,45150,000SHSOLE50,000 0 0
INHIBRX INCCOM45720L1075,608311,578SHSOLE311,578 0 0
ITEOS THERAPEUTICS INCCOM46565G1047,401300,000SHSOLE300,000 0 0
KALVISTA PHARMACEUTICALS INCCOM4834971033,777300,000SHSOLE300,000 0 0
KEROS THERAPEUTICS INCCOM49232710161,7121,600,000SHSOLE1,600,000 0 0
KYMERA THERAPEUTICS INCCOM5015751049,723300,920SHSOLE300,920 0 0
LARIMAR THERAPEUTICS INCCOM5171251005,006330,000SHSOLE330,000 0 0
LIFESCI ACQUISITION CORPUNIT 03/31/202553228P2085,440400,000SHSOLE400,000 0 0
NKARTA INCCOM65487U10861,5382,047,178SHSOLE2,047,178 0 0
NURIX THERAPEUTICS INCCOM67080M1039,600275,000SHSOLE275,000 0 0
OUTSET MED INCCOM6901451075,000100,000SHSOLE100,000 0 0
PANACEA ACQUISITION CORPUNIT 99/99/99996981022092,400200,000SHSOLE200,000 0 0
PANDION THERAPEUTICS INCCOM6983401065,157450,000SHSOLE450,000 0 0
PASSAGE BIO INCCOM7027121004,516344,438SHSOLE344,438 0 0
PLIANT THERAPEUTICS INCCOM7291391053,097136,715SHSOLE136,715 0 0
PMV PHARMACEUTICALS INCCOM69353Y1035,325150,000SHSOLE150,000 0 0
RAPT THERAPEUTICS INCCOM75382E1091,00131,100SHSOLE31,100 0 0
RELAY THERAPEUTICS INCCOM75943R1024,259100,000SHSOLE100,000 0 0
REPARE THERAPEUTICS INCCOM76027310230,059976,894SHSOLE976,894 0 0
SAGE THERAPEUTICS INCCOM78667J10815,280250,000SHSOLE250,000 0 0
SAREPTA THERAPEUTICS INCCOM80360710038,618275,000SHSOLE275,000 0 0
TG THERAPEUTICS INCCOM88322Q10846,8301,750,000SHSOLE1,750,000 0 0
THERAPEUTICS ACQUISITION CORCOM CL A88339T1037,190500,000SHSOLE500,000 0 0
UNUM THERAPEUTICS INCCOM9032141046,3182,700,000SHSOLE2,700,000 0 0